Chronic Myeloid Leukemia (CML) is a hematopoietic stem cell malignancy characterized by the acquisition of the t (9, 48) chromosomal translocation leading to expression of the BCR/ABL oncogene (52). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.